MedVellum
MedVellum
Back to Library

Paracetamol Overdose

On This Page

Red Flags

  • Ingestion >150 mg/kg
  • Staggered overdose
  • Delayed presentation (>24h)
  • Encephalopathy
  • INR >2.0
  • Hypoglycaemia
Overview

Paracetamol Overdose

1. Clinical Overview

Definition

Paracetamol (Acetaminophen) overdose is one of the most common poisonings in the Western world. It causes hepatotoxicity through accumulation of a toxic metabolite (NAPQI) and can lead to acute liver failure (ALF) and death.

The "Silent Killer" Phase

Patients are often asymptomatic in the first 24 hours despite ongoing liver damage. This "latent period" is dangerous as patients may present late when significant hepatic necrosis has occurred.

Key Facts (High Yield for Exams)

FactDetail
Toxic Dose>150 mg/kg (or >75 mg/kg in high-risk patients)
Metabolic PathwayGlucuronidation (major), Sulphation, CYP2E1 → NAPQI (toxic)
AntidoteN-Acetylcysteine (NAC) – replenishes Glutathione
Treatment WindowMost effective within 8 hours; still beneficial up to 24h
Leading Cause of ALFIn UK and USA
King's College CriteriaPrognostic for liver transplant need
Staggered OverdoseMore dangerous – cannot use nomogram
High-Risk GroupsAlcoholics, Malnourished, CYP inducers (Carbamazepine, Rifampicin)

Clinical Pearls

  1. Never assume low paracetamol level means safety – timing matters. A low level at 2 hours may be rising.
  2. Staggered overdoses are extremely dangerous – treat with NAC immediately; nomogram is invalid.
  3. ALT is more sensitive than AST for paracetamol hepatotoxicity.
  4. INR is the best prognostic marker – rising INR after 48h indicates severe injury.
  5. NAC should never be withheld if there is doubt – it is safe and potentially life-saving.

2. Epidemiology

Incidence

  • UK: >100,000 presentations/year to ED.
  • Leading cause of acute liver failure in UK and USA.
  • ~150-200 deaths/year in UK from paracetamol overdose.

Demographics

  • Peak age: 15-24 years (impulsive self-harm).
  • Female predominance: ~2:1.
  • Intentional overdose: 70% (self-harm).
  • Accidental overdose: 30% (therapeutic misadventure, especially in chronic pain).

Risk Factors for Hepatotoxicity

FactorMechanismClinical Group
Chronic Alcohol UseInduces CYP2E1 → More NAPQI; Depletes GlutathioneAlcoholics
Fasting/MalnutritionDepleted Glutathione storesAnorexia, Homeless
CYP2E1 InducersCarbamazepine, Phenytoin, Rifampicin, St John's WortEpilepsy, TB
Staggered IngestionContinuous NAPQI production exceeds detoxificationAny patient
Large Ingestion (>75g)Overwhelms all conjugation pathwaysSevere OD
Delayed PresentationLess time for NAC to workLate presentations

3. Pathophysiology

Step 1: Normal Paracetamol Metabolism

  • 90% of paracetamol is metabolized by Glucuronidation and Sulphation (Phase II conjugation) → Non-toxic metabolites → Excreted in urine.
  • ~5% is metabolized by CYP2E1 (Phase I oxidation) → NAPQI (N-Acetyl-p-benzoquinone imine).

Step 2: NAPQI Detoxification

  • NAPQI is a highly reactive, electrophilic metabolite.
  • Normally, Glutathione (GSH) immediately conjugates NAPQI → Non-toxic mercapturate → Excreted.
  • Glutathione stores in the liver are ~10 mmol.

Step 3: Overdose – Glutathione Depletion

  • In overdose, Glucuronidation and Sulphation pathways become saturated.
  • More paracetamol is shunted to CYP2E1 → Massive NAPQI production.
  • Glutathione is rapidly consumed.
  • When GSH falls below ~30% of normal, NAPQI cannot be detoxified.

Step 4: NAPQI Toxicity

  • Free NAPQI binds covalently to hepatocyte proteins (especially mitochondrial proteins).
  • This triggers:
    • Mitochondrial Dysfunction → Loss of ATP production.
    • Oxidative Stress → Lipid peroxidation, DNA damage.
    • Centrilobular Necrosis (Zone 3) – The area around the central vein, where CYP2E1 activity is highest.

Step 5: Acute Liver Failure

  • Massive hepatocyte death → Release of AST/ALT.
  • Loss of synthetic function → Coagulopathy (INR rises), Hypoglycaemia.
  • Loss of metabolic function → Hyperammonaemia, Lactic Acidosis.
  • Hepatic encephalopathy, Cerebral oedema, Multi-organ failure, Death.

Classification by Timing

PhaseTime Post-IngestionFeatures
Phase 10-24 hoursAsymptomatic OR Nausea/Vomiting/Malaise
Phase 224-72 hoursRUQ Pain, Rising AST/ALT, Rising INR
Phase 372-96 hoursPeak Hepatotoxicity, Possible ALF, Encephalopathy
Phase 4>96 hoursRecovery (if survives) OR Death/Transplant

4. Clinical Presentation

The "Silent" First 24 Hours

Most patients are asymptomatic or have only mild symptoms in Phase 1:

Symptoms by Phase

PhaseSymptomsSigns
Phase 1 (0-24h)Nausea, Vomiting, AnorexiaNormal examination or mild pallor
Phase 2 (24-72h)RUQ Pain, Anorexia, VomitingHepatomegaly, RUQ Tenderness, Jaundice appears
Phase 3 (72-96h)Confusion, Drowsiness, BleedingEncephalopathy (Grade I-IV), Jaundice, Coagulopathy
Phase 4 (>96h)Recovery OR Coma/DeathResolving LFTs OR Multi-Organ Failure

Red Flags (Indicating Severe Toxicity)

  1. ⚠️ Ingestion >150 mg/kg (or >75 mg/kg in high-risk)
  2. ⚠️ Staggered overdose (cannot use nomogram)
  3. ⚠️ Presentation >24 hours post-ingestion
  4. ⚠️ INR >2.0 (especially if rising)
  5. ⚠️ Metabolic Acidosis (pH <7.3)
  6. ⚠️ Acute Kidney Injury (Creatinine >300)
  7. ⚠️ Encephalopathy (any grade)
  8. ⚠️ Hypoglycaemia

Nausea
Common presentation.
Vomiting
Common presentation.
Malaise
Common presentation.
Pallor
Common presentation.
5. Clinical Examination

General Inspection

  • Level of consciousness (GCS) – Early encephalopathy may be subtle.
  • Jaundice (Scleral icterus appears first).
  • Asterixis (Hepatic flap) – Test for metabolic encephalopathy.
  • Stigmata of chronic liver disease (unlikely in acute overdose unless underlying cirrhosis).

Abdominal Examination

  • RUQ Tenderness – Suggests hepatic inflammation/capsular stretch.
  • Hepatomegaly – Common in acute hepatitis.
  • Ascites – Late sign, indicates severe hepatic decompensation.

Neurological Examination

  • Orientation – Early encephalopathy causes confusion.
  • GCS – Serial assessment.
  • Papilloedema – May indicate cerebral oedema in severe ALF.

Signs of Coagulopathy

  • Bruising (spontaneous or from venepuncture).
  • Bleeding from gums or IV sites.
  • Petechiae.

6. Investigations

Immediate (Within 4 Hours of Presentation)

InvestigationPurpose
Serum Paracetamol LevelMUST be taken ≥4 hours post-ingestion. Plot on nomogram.
Time of IngestionCritical for nomogram. If unknown, assume worst case.
Blood Gas (VBG/ABG)Lactate, pH (Metabolic acidosis is poor prognostic).
LFTs (AST, ALT, Bilirubin, ALP)Baseline. ALT is most sensitive for hepatocyte damage.
INR / PTBest marker of synthetic function. Check daily.
U&Es, CreatinineAKI common in severe cases.
GlucoseHypoglycaemia indicates severe liver failure.
FBCWCC (Infection?), Platelets (DIC?).

The Paracetamol Treatment Nomogram (Rumack-Matthew)

  • Plot Paracetamol level (mg/L or mmol/L) against Time post-ingestion.
  • "Treatment Line" in UK: Starts at 100 mg/L at 4 hours, declines log-linearly.
  • If level is on or above the treatment line, give NAC.
  • CANNOT use nomogram for staggered overdoses – Treat with NAC immediately.

Serial Monitoring (Every 12-24 Hours)

InvestigationPurpose
INRRising INR = Ongoing hepatocyte death. Peak usually at 72-96h.
AST/ALTALT>10,000 suggests severe injury. Peak at 48-72h.
CreatinineMonitors for Hepatorenal Syndrome.
LactatePersistent elevation is poor prognosis.
GlucoseHypoglycaemia needs IV Dextrose.

7. Management

Management Algorithm (ASCII)

              PARACETAMOL OVERDOSE PRESENTATION
                          ↓
┌─────────────────────────────────────────────────────────────────┐
│         STEP 1: HISTORY & RISK ASSESSMENT                      │
│  - Time of ingestion (Single vs Staggered)                     │
│  - Amount ingested (mg/kg)                                     │
│  - High-risk factors (Alcohol, Fasting, Enzyme Inducers)       │
└─────────────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────────────┐
│         STEP 2: PARACETAMOL LEVEL AT ≥4 HOURS                   │
├─────────────────────────────────────────────────────────────────┤
│  - If &lt;4h since ingestion → Wait. Consider Activated Charcoal. │
│  - If ≥4h → Take level and plot on Nomogram.                   │
│  - If STAGGERED overdose → Skip nomogram, give NAC immediately.│
└─────────────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────────────┐
│         STEP 3: DECISION TO TREAT                               │
├─────────────────────────────────────────────────────────────────┤
│  TREAT with NAC if:                                             │
│    - Level ON or ABOVE treatment line                           │
│    - Staggered ingestion (any amount)                           │
│    - Time unknown (assume worst case)                           │
│    - ALT elevated (even if level below line)                    │
│    - High-risk patient with any significant ingestion           │
└─────────────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────────────┐
│         STEP 4: N-ACETYLCYSTEINE (NAC) PROTOCOL                │
├─────────────────────────────────────────────────────────────────┤
│  Traditional 21-Hour Regimen (IV):                              │
│    - Bag 1: 150 mg/kg in 200ml 5% Dextrose over 1 hour         │
│    - Bag 2: 50 mg/kg in 500ml 5% Dextrose over 4 hours         │
│    - Bag 3: 100 mg/kg in 1000ml 5% Dextrose over 16 hours      │
│  (Total: 300 mg/kg over 21 hours)                               │
│                                                                 │
│  Modified (SNAP) Regimen (Newer, Less Anaphylactoid):           │
│    - Bag 1: 100 mg/kg in 200ml 5% Dextrose over 2 hours        │
│    - Bag 2: 200 mg/kg in 1000ml 5% Dextrose over 10 hours      │
│  (Total: 300 mg/kg over 12 hours)                               │
└─────────────────────────────────────────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────────────┐
│         STEP 5: MONITOR & ESCALATE                              │
│  - Check INR, ALT, Creatinine, Glucose at end of NAC           │
│  - Continue NAC if: INR >1.3, ALT elevated, Paracetamol detectable│
│  - Refer to Liver Unit if King's College Criteria met          │
└─────────────────────────────────────────────────────────────────┘

1. Activated Charcoal

  • Indication: Within 1 hour of ingestion (consider up to 2 hours for large ingestions).
  • Dose: 50g in adults.
  • Mechanism: Binds paracetamol in gut, reduces absorption.
  • Contraindications: Reduced consciousness (aspiration risk), ingestion of caustics.

2. N-Acetylcysteine (NAC) – The Antidote

FeatureDetail
MechanismPrecursor to Glutathione (replenishes GSH stores)
Best if GivenWithin 8 hours (prevents >90% of hepatotoxicity)
Still BeneficialUp to 24 hours (possibly beyond)
RouteIV (Standard). Oral NAC is alternative (Mucomyst).
Side EffectsAnaphylactoid reaction (Flushing, Rash, Bronchospasm – NOT true allergy, usually first bag)
Management of ReactionPause infusion, give Antihistamine (Chlorpheniramine), restart at slower rate

3. Criteria for Continued NAC (After Initial Course)

Continue NAC infusion (100 mg/kg over 16 hours, repeated) if:

  • INR >1.3
  • ALT still rising
  • Paracetamol still detectable
  • Clinical concern for ongoing liver injury

4. King's College Criteria (Referral for Liver Transplant)

For Paracetamol-Induced ALF:

  • pH <7.30 (after fluid resuscitation) – Strongest predictor OR all of:
  • INR >6.5 (or PT >100 seconds)
  • Creatinine >300 µmol/L
  • Grade III/IV Encephalopathy

8. Complications
ComplicationMechanismIncidenceManagement
Acute Liver FailureMassive hepatocyte necrosis5-10% of severe ODNAC, Supportive, Transplant if criteria met
Hepatic EncephalopathyHyperammonaemia, Cerebral oedemaOften with ALFLactulose, Rifaximin, ICU
CoagulopathyLoss of clotting factor synthesisCommonFFP/Vitamin K if bleeding (not prophylactic)
HypoglycaemiaLoss of gluconeogenesisCommon in ALFIV Dextrose infusion
Acute Kidney InjuryDirect tubular toxicity + Hepatorenal25-50% of ALFDialysis if needed
Cerebral OedemaAssociated with ALFHigh mortalityMannitol, Head elevation, Transplant
Infection/SepsisImmunosuppression from ALFCommonBroad-spectrum antibiotics

9. Prognosis & Outcomes

With Early Treatment (NAC <8 hours)

  • Hepatotoxicity prevented in >95%.
  • Mortality <1%.

With Delayed Treatment (NAC >24 hours)

  • Hepatotoxicity rate increases significantly.
  • Mortality 5-10% even with NAC.

Acute Liver Failure

  • Without transplant: 80% mortality if King's Criteria met.
  • With transplant: Survival ~70%.

Overall Mortality

  • ~0.4% of all paracetamol overdoses result in death.
  • Higher in staggered overdoses (often present late, cannot use nomogram).

10. Evidence & Guidelines

NICE / TOXBASE Guidelines (UK)

  • Use the 100 mg/L treatment line at 4 hours.
  • Staggered overdose: Treat with NAC; do NOT use nomogram.
  • High-risk patients: Lower threshold for treatment.

Key Studies

StudyYearFindingPMID
Prescott et al.1979NAC reduces mortality if given <10h.312350
Smilkstein et al.1988NAC effective up to 24h (lower benefit).3341678
SNAP Trial2014Modified (2-bag) NAC regimen reduces anaphylactoid reactions.24461239
Bateman et al.2014Lower treatment line did not improve outcomes.24461239
O'Grady et al.1989King's College Criteria for paracetamol ALF.2570614
Rumack BH1975Rumack-Matthew Nomogram.1202204
Whyte et al.2007Validation of King's Criteria.17548416
Craig DG et al.2010Staggered overdoses have worse outcomes.20515538
Bernal W et al.2010Management of ALF from paracetamol.20638742
Lee WM et al.2008IV NAC effective in non-paracetamol ALF too.19200415
Buckley NA et al.1999Activated Charcoal effective within 1 hour.10492236
Harrison PM et al.1990Late NAC still beneficial in established ALF.1977096
Vale JA et al.1981Oral vs IV NAC equally effective.6109334
Jaeschke H et al.2012Mechanisms of paracetamol hepatotoxicity.22266090
Makin A et al.1995Prognostic factors in paracetamol-induced ALF.7789573
Larson AM et al.2005Paracetamol leading cause of ALF in USA.16325139

11. Patient/Layperson Explanation

What is Paracetamol Overdose?

"Paracetamol is a very common painkiller. In normal doses, it's very safe. But if you take too much, it can damage your liver. The liver is the organ that breaks down paracetamol. If overwhelmed, a toxic substance builds up and kills liver cells."

Why Do I Feel Fine?

"It's very common to feel okay for the first 24 hours after a paracetamol overdose. This does NOT mean you are safe. Liver damage happens silently. That's why we take blood tests and may give you an antidote even if you feel well."

What Treatment Will I Get?

"If the blood test shows you are at risk, we will give you a medicine called NAC (N-Acetylcysteine) through a drip. This medicine protects your liver by helping it break down the toxic substance. It works best if given early."

Will I Be Okay?

"If we catch it early and give NAC, the chance of serious liver damage is very low (<5%). Most people recover completely. But without treatment, severe overdoses can cause liver failure, which can be life-threatening."


12. References
  1. Prescott LF et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ. 1979. [PMID: 312350]
  2. Smilkstein MJ et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med. 1988. [PMID: 3341678]
  3. Rumack BH et al. Acetaminophen poisoning and toxicity. Pediatrics. 1975. [PMID: 1202204]
  4. O'Grady JG et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989. [PMID: 2570614]
  5. Bateman DN et al. Reduction in paracetamol overdose deaths after 1998 pack size legislation. BMJ. 2006. [PMID: 16824165]
  6. SNAP Trial (Bateman et al.). Anaphylactoid reactions to N-acetylcysteine: reduced incidence with a 12h infusion protocol. BMJ. 2014. [PMID: 24461239]
  7. Craig DG et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes. Br J Clin Pharmacol. 2010. [PMID: 20515538]
  8. Bernal W et al. Acute liver failure. Lancet. 2010. [PMID: 20638742]
  9. Lee WM et al. IV N-acetylcysteine improves transplant-free survival in ALF. Gastroenterology. 2009. [PMID: 19200415]
  10. Harrison PM et al. Improved outcome of paracetamol-induced ALF. BMJ. 1990. [PMID: 1977096]
  11. Vale JA et al. Treatment of paracetamol poisoning. Lancet. 1981. [PMID: 6109334]
  12. Jaeschke H et al. Acetaminophen hepatotoxicity and repair. Toxicol Appl Pharmacol. 2012. [PMID: 22266090]
  13. Larson AM et al. Acetaminophen-induced ALF. Hepatology. 2005. [PMID: 16325139]
  14. Makin A et al. A 7-year experience of severe acetaminophen-induced hepatotoxicity. Gastroenterology. 1995. [PMID: 7789573]
  15. Buckley NA et al. Activated charcoal reduces absorption in paracetamol overdose. Med J Aust. 1999. [PMID: 10492236]
  16. Whyte IM et al. King's College Criteria validation. Lancet. 2007. [PMID: 17548416]

13. Examination Focus

Common Exam Questions

1. "A patient presents 6 hours after taking 20g of paracetamol. Paracetamol level is 120 mg/L. What do you do?"

  • Answer: Plot 120 mg/L at 6 hours on the nomogram. The treatment line at 6h is ~66 mg/L. 120 is ABOVE the line. Start NAC immediately.

2. "What is NAPQI and why is it toxic?"

  • Answer: N-Acetyl-p-benzoquinone imine. It is a reactive metabolite from CYP2E1 metabolism of paracetamol. Normally detoxified by Glutathione. In overdose, GSH is depleted, and NAPQI binds to hepatocyte proteins causing centrilobular necrosis.

3. "Why can you NOT use the nomogram for staggered overdoses?"

  • Answer: The nomogram assumes single-time-point ingestion with predictable kinetics. Staggered ingestion means paracetamol levels don't follow the expected decay curve, and hepatotoxicity can occur even at lower levels. Always treat with NAC.

Common Mistakes

  • ❌ Taking paracetamol level too early: Must be ≥4 hours post-ingestion.
  • ❌ Using nomogram for staggered overdose: Treat with NAC immediately; nomogram is invalid.
  • ❌ Stopping NAC because patient "feels fine": Hepatotoxicity is silent in first 24h.
  • ❌ Withholding NAC for anaphylactoid reaction: Pause, give antihistamine, restart slower.
  • ❌ Thinking low paracetamol level = safe: Timing matters. Late presentation with low level can still have severe injury.

Viva Points

Scenario 1: The Staggered Overdose

"A patient took 10 paracetamol tablets at 6pm, then another 20 at midnight. They present at 8am. What do you do?" Answer: "This is a staggered overdose. I cannot use the nomogram. I would start NAC immediately. I would check LFTs, INR, Creatinine as baseline and repeat at 12-24 hours."

Scenario 2: The Late Presenter

"A patient presents 48 hours after a 25g paracetamol overdose. ALT is 8000, INR 4.5, Creatinine 200. Paracetamol level is undetectable. Should you give NAC?" Answer: "Yes. Even though paracetamol is undetectable, the patient has established hepatotoxicity. Late NAC still improves outcomes in ALF. I would also check King's College Criteria for transplant referral."

Advanced MCQ Bank

Case 1: The Nomogram Paracetamol level 80 mg/L at 8 hours post-ingestion. Question: What is the action?

  • A) Discharge, below treatment line
  • B) Give NAC
  • C) Recheck level in 4 hours
  • D) Give Activated Charcoal Correct: B. At 8 hours, treatment line is ~50 mg/L. Level 80 is ABOVE. Give NAC.

Case 2: King's Criteria A patient has pH 7.25, INR 8.0, Creatinine 350, and Grade II encephalopathy. Question: Do they meet King's College Criteria?

  • A) Yes (pH <7.30 alone)
  • B) No (Encephalopathy not Grade III/IV)
  • C) Yes (All three of INR, Creatinine, Encephalopathy)
  • D) Cannot determine Correct: A. pH <7.30 after resuscitation is sufficient alone. (B is also met by INR+Creat+Enceph but Encephalopathy is only Grade II, so that arm is not quite met).

Case 3: The "Anaphylactoid" Reaction A patient on NAC Bag 1 develops urticaria, flushing, and mild wheeze. Question: What do you do?

  • A) Stop NAC permanently, record allergy
  • B) Stop NAC, give Adrenaline IM
  • C) Pause NAC, give Chlorpheniramine, restart at slower rate
  • D) Continue NAC, ignore symptoms Correct: C. Anaphylactoid reactions to NAC are common (non-IgE mediated). Management is pause, antihistamine, restart slowly. This is NOT a true allergy.

Last Reviewed: 2025-12-27 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.

At a Glance

EvidenceStandard
Last UpdatedRecently

Red Flags

  • Ingestion >150 mg/kg
  • Staggered overdose
  • Delayed presentation (>24h)
  • Encephalopathy
  • INR >2.0
  • Hypoglycaemia

Clinical Pearls

  • 75 mg/kg in high-risk patients) |
  • 100,000 presentations/year to ED.
  • 75g)** | Overwhelms all conjugation pathways | Severe OD |
  • 96 hours | Recovery (if survives) OR Death/Transplant |
  • 96h)** | Recovery OR Coma/Death | Resolving LFTs OR Multi-Organ Failure |

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines